@phdthesis{RinconOrozco2007, author = {Rinc{\´o}n Orozco, Bladimiro}, title = {TCR and CO-receptors mediated activation of V gamma 9V delta 2 T cells}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-24902}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2007}, abstract = {A small percentage (1-5\%) of the blood lymphocytes expresses alternative T-cell antigen receptor that uses g and d TCR rearranging genes. A subset of them expresses the Vg9Vd2 TCR. Those cells respond to self-nonpeptide and foreign antigens presented by unknown antigen-presenting molecules. Vg9Vd2 T cells also express Toll-like receptors and natural killer receptors that allow them to respond to other nonpeptide microbial components or to alterations in the expression of stress cell surface ligands such as NKG2D ligands. Vg9Vd2 T cells frequently are regulated by the expression of activating and/or inhibitory NKRs (iNKRs) that can fine-tune their activation threshold and the activating NKG2D receptor is one of the most studied until now. NKG2D, a C-type lectin receptor directed against MICA/MICB and UL16-binding protein (ULBP) molecules, have been reported a powerful co-stimulus for Ag-mediated activation of CD8 and Vg9Vd2 T cells. Indeed, NKG2D is recruited within the Vg9Vd2 TCR immunological synapse and enhances recognition by Vg9Vd2 T cells of Mycobacteria-infected DCs and various MICA/MICB or ULBP hemopoietic and non-hemopoietic tumors. The level of NKG2D is upregulated by inflammatory cytokines (e.g. IL-15), and NKG2D ligands are induced after a physical or genotoxic stress and/or along infection by intracellular pathogens. Therefore, NKG2D is a key stress sensor that strongly enhances recognition of altered or infected self by human gd T cells. Recent progress in the field supports the idea that gd T cells fulfill a role in the innate and adaptative immune response in different way of the conventional ab T cells. We demonstrated direct activation of Vg9Vd2 T cells by NKG2D ligation through the association with DAP10 adapter molecules and independently of TCR-Ag recognition, similar to the NKG2D-mediated activation of NK cells. Culture of peripherical blood mononuclear cells with immobilized NKG2D mAb or NKG2D ligand MICA induces up-regulation of CD69 and CD25 in NK and Vg9Vd2 T cells but not in CD8 T cells. Additionally, the ligation of NKG2D induces in Vg9Vd2 T cells the up-regulation of molecules typical for antigenpresenting cells, such as co-stimulator molecules (CD86) antigen presenting molecules (CD1a, HLA-DR), adhesion molecules (CD54), and activation molecules (CD69). Furthermore, NKG2D ligation in Vg9Vd2 T cells induces the production of cytokines such as TNF-a and chemokines such as, MIP-1a, but cannot induce the production of cytokines such as IL-6 or IFN-g and chemokines such as RANTES, MCP-1 and GM-CSF. In addition, NKG2D triggers the activation of the cytolytic machinery as efficient as CD3 stimulation as shown by measurement of the release of granules with esterase activity (BLT assay), perforin and the up-regulation of CD107a on the surface of Vg9Vd2 T cells. This NKG2D dependent cytolysis has been confirmed using purified Vg9Vd2 T cells, which kill MICA-transduced RMA cells but not the control cells. The TCR independence and NKG2D dependence of this killing is supported by mAb inhibition experiment. Finally, DAP 10, which mediates NKG2D signaling of human NK cells, is found in resting and activated Vg9Vd2 T cells. Moreover, data of intracellular signaling studies suggest an important role of Scr kinases in the NKG2D mediated killing and involvement of DAP-10-PI3K and PLCg 1 pathways as mayor proteins implicated in target cell lysis, and shows remarkable difference with the TCR signaling. The identification of these similarities in NKG2D function between NK and Vg9Vd2 T cells may be of interest for development of new strategies for Vg9Vd2 T cell-based immunotherapy in certain types of cancer and help to understand Vg9Vd2 T cell function in general.}, subject = {TCR}, language = {en} }